Literature DB >> 24390334

Dimerization of flavivirus NS4B protein.

Jing Zou1, Xuping Xie, Le Tian Lee, Ramya Chandrasekaran, Aline Reynaud, Lijian Yap, Qing-Yin Wang, Hongping Dong, Congbao Kang, Zhiming Yuan, Julien Lescar, Pei-Yong Shi.   

Abstract

UNLABELLED: Flavivirus replication is mediated by a complex machinery that consists of viral enzymes, nonenzymatic viral proteins, and host factors. Many of the nonenzymatic viral proteins, such as NS4B, are associated with the endoplasmic reticulum membrane. How these membrane proteins function in viral replication is poorly understood. Here we report a robust method to express and purify dengue virus (DENV) and West Nile virus NS4B proteins. The NS4B proteins were expressed in Escherichia coli, reconstituted in dodecyl maltoside (DDM) detergent micelles, and purified to >95% homogeneity. The recombinant NS4B proteins dimerized in vitro, as evidenced by gel filtration, chemical cross-linking, and multiangle light scattering experiments. The dimeric form of NS4B was also detected when the protein was expressed alone in cells as well as in cells infected with DENV type 2 (DENV-2). Mutagenesis analysis showed that the cytosolic loop (amino acids 129 to 165) and the C-terminal region (amino acids 166 to 248) are responsible for NS4B dimerization. trans-Complementation experiments showed that (i) two genome-length RNAs containing distinct NS4B lethal mutations could not trans-complement each other, (ii) the replication defect of NS4B mutant RNA could be restored in cells containing DENV-2 replicons, and (iii) expression of wild-type NS4B protein alone was not sufficient to restore the replication of the NS4B mutant RNA. Collectively, the results indicate that trans-complementation of a lethal NS4B mutant RNA requires wild-type NS4B presented from a replication complex. IMPORTANCE: The reported expression and purification system has made it possible to study the biochemistry and structure of flavivirus NS4B proteins. The finding of flavivirus NS4B dimerization and the mapping of regions important for NS4B dimerization provide the possibility to inhibit viral replication through blocking NS4B dimerization. The requirement of NS4B in the context of the replication complex for successful trans-complementation enhances our understanding of NS4B in flavivirus replication.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390334      PMCID: PMC3957939          DOI: 10.1128/JVI.02782-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner.

Authors:  Sven Miller; Stefan Kastner; Jacomine Krijnse-Locker; Sandra Bühler; Ralf Bartenschlager
Journal:  J Biol Chem       Date:  2007-02-02       Impact factor: 5.157

2.  Palmitoylation and polymerization of hepatitis C virus NS4B protein.

Authors:  Guann-Yi Yu; Ki-Jeong Lee; Lu Gao; Michael M C Lai
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA.

Authors:  Indira Umareddy; Alex Chao; Aruna Sampath; Feng Gu; Subhash G Vasudevan
Journal:  J Gen Virol       Date:  2006-09       Impact factor: 3.891

4.  West Nile virus 5'-cap structure is formed by sequential guanine N-7 and ribose 2'-O methylations by nonstructural protein 5.

Authors:  Debashish Ray; Aaloki Shah; Mark Tilgner; Yi Guo; Yiwei Zhao; Hongping Dong; Tia S Deas; Yangsheng Zhou; Hongmin Li; Pei-Yong Shi
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization.

Authors:  Marie-Pierre Egloff; Delphine Benarroch; Barbara Selisko; Jean-Louis Romette; Bruno Canard
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

6.  De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase.

Authors:  M Ackermann; R Padmanabhan
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

7.  RNA-stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria.

Authors:  P Warrener; J K Tamura; M S Collett
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  In vitro synthesis of West Nile virus proteins indicates that the amino-terminal segment of the NS3 protein contains the active centre of the protease which cleaves the viral polyprotein after multiple basic amino acids.

Authors:  G Wengler; G Czaya; P M Färber; J H Hegemann
Journal:  J Gen Virol       Date:  1991-04       Impact factor: 3.891

9.  Inhibition of interferon signaling by dengue virus.

Authors:  Jorge L Muñoz-Jordan; Gilma G Sánchez-Burgos; Maudry Laurent-Rolle; Adolfo García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

10.  Detergent structure and associated lipid as determinants in the stabilization of solubilized Ca2+-ATPase from sarcoplasmic reticulum.

Authors:  S Lund; S Orlowski; B de Foresta; P Champeil; M le Maire; J V Møller
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

View more
  32 in total

1.  Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assembly.

Authors:  Xuping Xie; Jing Zou; Chunya Puttikhunt; Zhiming Yuan; Pei-Yong Shi
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Mutation of Putative N-Glycosylation Sites on Dengue Virus NS4B Decreases RNA Replication.

Authors:  Nenavath Gopal Naik; Huey-Nan Wu
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

3.  Determinants of Dengue Virus NS4A Protein Oligomerization.

Authors:  Chia Min Lee; Xuping Xie; Jing Zou; Shi-Hua Li; Michelle Yue Qi Lee; Hongping Dong; Cheng-Feng Qin; Congbao Kang; Pei-Yong Shi
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

4.  Characterization of dengue virus NS4A and NS4B protein interaction.

Authors:  Jing Zou; Xuping Xie; Qing-Yin Wang; Hongping Dong; Michelle Yueqi Lee; Congbao Kang; Zhiming Yuan; Pei-Yong Shi
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

5.  A West Nile virus NS4B-P38G mutant strain induces cell intrinsic innate cytokine responses in human monocytic and macrophage cells.

Authors:  Guorui Xie; Huanle Luo; Bing Tian; Brian Mann; Xiaoyong Bao; Jere McBride; Robert Tesh; Alan D Barrett; Tian Wang
Journal:  Vaccine       Date:  2015-01-03       Impact factor: 3.641

6.  Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach.

Authors:  Chao Shan; Xuping Xie; Jing Zou; Roland Züst; Bo Zhang; Rebecca Ambrose; Jason Mackenzie; Katja Fink; Pei-Yong Shi
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

7.  Mapping the Interactions between the NS4B and NS3 proteins of dengue virus.

Authors:  Jing Zou; Le Tian Lee; Qing Yin Wang; Xuping Xie; Siyan Lu; Yin Hoe Yau; Zhiming Yuan; Susana Geifman Shochat; Congbao Kang; Julien Lescar; Pei-Yong Shi
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

8.  A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication.

Authors:  Laurent Chatel-Chaix; Wolfgang Fischl; Pietro Scaturro; Mirko Cortese; Stephanie Kallis; Marie Bartenschlager; Bernd Fischer; Ralf Bartenschlager
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

9.  A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein.

Authors:  Fang Guo; Shuo Wu; Justin Julander; Julia Ma; Xuexiang Zhang; John Kulp; Andrea Cuconati; Timothy M Block; Yanming Du; Ju-Tao Guo; Jinhong Chang
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

Review 10.  ER functions are exploited by viruses to support distinct stages of their life cycle.

Authors:  Yu-Jie Chen; Parikshit Bagchi; Billy Tsai
Journal:  Biochem Soc Trans       Date:  2020-10-30       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.